About
Adam Freund is the founder and CEO of Arda Therapeutics, a biotech company developing targeted cell depletion therapies for chronic diseases and aging-related conditions. Before founding Arda, he was a Principal Investigator at Calico Life Sciences, where he led multiple therapeutic programs and helped scale the company. He trained in molecular and cell biology at UC Berkeley and conducted postdoctoral work at Stanford.
Areas of interest
longevityaging biologybiotechdrug discoverysingle-cell biologycomputational biologytherapeuticschronic diseasefibrosisautoimmune disease